Protalix BioTherapeutics (PLX) Reports Q4 Loss of $0.29/Share

Go back to Protalix BioTherapeutics (PLX) Reports Q4 Loss of $0.29/Share
PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) Delayed: 2.17 +0.01 (0.46%)
Previous Close $2.16    52 Week High $1.11 
Open $2.15    52 Week Low $0.41 
Day High $2.23    P/E N/A 
Day Low $2.13    EPS $-0.29 
Volume 347,441